History and Development of ABCA1
- 16 August 2023
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102036
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Foam cells in atherosclerosisClinica Chimica Acta, 2013
- Immunity, atherosclerosis and cardiovascular diseaseBMC Medicine, 2013
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisJournal of Clinical Investigation, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- MiR-33 Contributes to the Regulation of Cholesterol HomeostasisScience, 2010
- MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol HomeostasisScience, 2010
- TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2Journal of Lipid Research, 2010
- Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune ResponsesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoJournal of Clinical Investigation, 2007